1.
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016:...
by Abate, Kalkidan Hassen
The Lancet (British edition), 2017, Vol.390 (10100), p.1260-1344

2.
Lifestyle behaviours and quality-adjusted life years in middle and older age
by Myint, Phyo K
Age and ageing, 2011, Vol.40 (5), p.589-595

3.
The statewide burden of obesity, smoking, low income and chronic diseases in the United States
by Jia, Haomiao
Journal of public health (Oxford, England), 2009, Vol.31 (4), p.496-505

4.
The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study
by Ding, Hanyue
Vaccine, 2022, Vol.40 (9), p.1282-1288

5.
Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact
by Christensen, Hannah
Vaccine, 2013, Vol.31 (23), p.2638-2646

6.
Cost-effectiveness analysis of influenza vaccination during pregnancy in Japan
by Hoshi, Shu-ling
Vaccine, 2020, Vol.38 (46), p.7363-7371

7.
REFINE (REducing Falls in In-patieNt Elderly) using bed and bedside chair pressure sensors linked to radio-pagers in acute hospital care: a randomised controlled trial
by Sahota, Opinder
Age and ageing, 2014, Vol.43 (2), p.247-253

8.
Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan
by Hoshi, Shu-ling
Vaccine, 2018, Vol.36 (34), p.5133-5140

9.

10.
Surgical Management of Trigeminal Neuralgia: Use and Cost-Effectiveness From an Analysis of the Medicare Claims Database
by Sivakanthan, Sananthan
Neurosurgery, 2014, Vol.75 (3), p.220-226

11.
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
by Grosse, Scott D
Expert review of pharmacoeconomics & outcomes research, 2008, Vol.8 (2), p.165-178

12.
A Pilot Cost-Effectiveness Analysis of Treatments in Newly Diagnosed High-Grade Gliomas: The Example of 5-Aminolevulinic Acid Compared With White-Light Surgery
by Esteves, Susana
Neurosurgery, 2015, Vol.76 (5), p.552-562

13.
Cost-Effectiveness of Nalmefene Added to Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol-Dependent Patients With High/Very High Drinking Risk Levels: A Mic...
by Millier, Aurélie
Journal of studies on alcohol and drugs, 2017, Vol.78 (6), p.867-876

14.
Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan
by Hoshi, Shu-ling
Vaccine, 2017, Vol.35 (24), p.3264-3271

15.
Option appraisal of population-based colorectal cancer screening programmes in England
by Tappenden, Paul
Gut, 2007, Vol.56 (5), p.677-684

16.
Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review
by Wong, Carlos K.H
Vaccine, 2017, Vol.35 (24), p.3153-3161

17.
Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: Adjusting quality-of-life and lead-time bias for utility of...
by Yang, Szu-Chun
Lung cancer (Amsterdam, Netherlands), 2014, Vol.86 (1), p.96-101

18.
Five preference-based indexes in cataract and heart failure patients were not equally responsive to change
by Kaplan, Robert M
Journal of clinical epidemiology, 2011, Vol.64 (5), p.497-506

19.
Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects
by Tilford, JM
Journal of autism and developmental disorders, 2015, Vol.45 (11), p.3613-3623

20.
Validating the EQ-5D with Time Trade off for the German Population
by Greiner, W
The European journal of health economics, 2005, Vol.6 (2), p.124-130
